The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
bleomycin sulfate · Powder
4 marketed package NDCs · 3 active manufacturers
Most dispensed: 15 [USP'U] · Injection, Powder, Lyophilized, For Solution · #1 vial/carton / 1 injection, powder, lyophilized, for solution in 1 vial · 15 [USP'U] · Powder, For Solution · #1 vial, single-dose/carton / 15 powder, for solution in 1 vial, single-dose
Same drug class
Other molecules FDA puts in Cytoprotective Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Bleomycin sulfate in shortage right now?
- No. FDA does not currently list Bleomycin sulfate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Bleomycin sulfate?
- 5 companies have marketed Bleomycin sulfate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Bleomycin sulfate cost?
- The typical pharmacy pays about $26.45 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.